Latest filings (excl ownership)
8-K
Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
3 May 24
8-K
Other Events
10 Apr 24
EFFECT
Notice of effectiveness
8 Apr 24
424B3
Prospectus supplement
5 Apr 24
8-K
Amendments to Articles of Incorporation or Bylaws
5 Apr 24
S-3
Shelf registration
29 Mar 24
S-8
Registration of securities for employees
29 Mar 24
8-K
Results of Operations and Financial Condition
27 Mar 24
10-K
2023 FY
Annual report
26 Mar 24
8-K
Departure of Directors or Certain Officers
6 Mar 24
8-K
Departure of Directors or Certain Officers
13 Feb 24
D
$2.50 mm in options / securities to be acquired, sold $2.50 mm, 15 investors
13 Feb 24
DEFA14A
Additional proxy soliciting materials
6 Feb 24
DEF 14A
Definitive proxy
6 Feb 24
424B3
Prospectus supplement
1 Feb 24
424B3
Prospectus supplement
1 Feb 24
424B3
Prospectus supplement
1 Feb 24
424B3
Prospectus supplement
1 Feb 24
8-K
Entry into a Material Definitive Agreement
1 Feb 24
8-K
Palisade Bio Announces Positive Preclinical Data of Lead Program
29 Jan 24
PRE 14A
Preliminary proxy
26 Jan 24
RW
Registration withdrawal request
26 Jan 24
S-1
IPO registration
29 Dec 23
10-Q
2023 Q3
Quarterly report
9 Nov 23
8-K
Regulation FD Disclosure
7 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
20 Oct 23
S-8
Registration of securities for employees
14 Sep 23
8-K
Entry into a Material Definitive Agreement
11 Sep 23
8-K
Entry into a Material Definitive Agreement
11 Sep 23
424B5
Prospectus supplement for primary offering
11 Sep 23
8-K
Entry into a Material Definitive Agreement
8 Sep 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
8-K
Entry into a Material Definitive Agreement
9 Jun 23
10-Q
2023 Q1
Quarterly report
11 May 23
EFFECT
Notice of effectiveness
28 Apr 23
424B3
Prospectus supplement
27 Apr 23
CORRESP
Correspondence with SEC
27 Apr 23
S-1/A
IPO registration (amended)
26 Apr 23
UPLOAD
Letter from SEC
25 Apr 23
S-1
IPO registration
21 Apr 23
Latest ownership filings
4
John David Finley
12 Mar 24
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 24
SC 13G/A
Lind Global Fund II LP
13 Feb 24
4
James R Neal
13 Feb 24
4
Cristina Csimma
13 Feb 24
4
Robert J. Trenschel
13 Feb 24
4
Stephanie Diaz
13 Feb 24
SC 13G/A
L1 Capital Global Opportunities Master Fund, Ltd.
9 Feb 24
4
Mitchell Lawrence Jones
8 Feb 24
4
John David Finley
8 Feb 24
4
John David Finley
7 Feb 24
SC 13G/A
INTRACOASTAL CAPITAL, LLC
6 Feb 24
4
John David Finley
1 Feb 24
4
Donald Allen Williams
1 Feb 24
4
John David Finley
5 Jan 24
4
John David Finley
19 Dec 23
4
Donald Allen Williams
24 Nov 23
4
Mitchell Lawrence Jones
24 Nov 23
4
Robert J. Trenschel
24 Nov 23
4
James R Neal
24 Nov 23
4
Stephanie Diaz
24 Nov 23
4
MARY ANN GRAY
24 Nov 23
4
John David Finley
24 Nov 23
4
Binxian Wei
24 Nov 23
4
Cristina Csimma
24 Nov 23
4
Mitchell Lawrence Jones
8 Nov 23
4
John David Finley
8 Nov 23
4
John David Finley
5 Oct 23
4
Donald Allen Williams
29 Sep 23
4
John David Finley
29 Sep 23
4
Robert J. Trenschel
15 Sep 23
SC 13G
L1 Capital Global Opportunities Master Fund, Ltd.
15 Sep 23
SC 13G
Lind Global Fund II LP
15 Sep 23
4
John David Finley
14 Sep 23
3
Mitchell Lawrence Jones
13 Sep 23
4
John David Finley
13 Sep 23
4
John David Finley
14 Aug 23
4
John David Finley
6 Jul 23
4
John David Finley
14 Jun 23
4
Robert J. Trenschel
13 Jun 23